My mission is to reverse aging in all 81 organ types.
I empower patients and clinicians to transform their health and longevity with science-backed solutions.
- Dr Oliver Zolman
The Longevity Level 1, 2, 3 Protocol
How to live to 100+ Newsletter
Dr Oliver Zolman MBBS BSc is a leading longevity doctor and scientist specialising in evidence-based longevity and experimental rejuvenation medicine. A graduate of King’s College London, he holds a First Class Honours degree in Regenerative Medicine and completed a Visiting Fellowship in Evidence-Based Medicine at the University of Sydney.
Oliver is at the forefront of ageing research, aiming to reverse biological aging across all 81 organ types and achieve longevity escape velocity (LEV) by 2030. As the founder of 20one Consulting, Dr Zolman applies cutting-edge science to create personalised, results-driven health and longevity strategies.
His work has been featured in the BBC, Bloomberg, The Times, Guardian, New York Post, Piers Morgan, GQ, Rolling Stone, The Onion, and the 2025 Netflix Documentary "Don't Die".
Dr Zolman's Work
Longevity School
Dr Zolman created a new medical specialty (LEVMED) with its own peer-reviewed AGREE2/IPDAS compliant clinical practice guidelines around the Level 123 protocol, to test if it outperforms standard care and achieves LEV. Pseudoscience free. longevity.school
Dr Zolman's Health Calculators
Based on international clinical guidelines (the highest form of evidence in medicine), see your longevity screening tests and more.
Project MouseSpan
Coming soon
Rejuvenation Leaderboards
Dr Zolman created the field of evidence-based competitive rejuvenation, through the Zolman Rejuvenation Leaderboards on his website (in update).
Level 1, 2, 3 Longevity Protocol
Dr Zolman created the Level 1, 2, 3 protocol to integrate all current & future aging tests and therapies as a single personalised adaptive health protocol to prove N=1 rejuvenation in all organs, which is taught in Longevity School.
The 81 Organ Framework & Zolman Clocks
Dr Zolman created the concept of measuring aging in all 81 organ types, using Zolman Clocks, with biostatistical rigour (publications pending) to prove rejuvenation & N=1 LEV.
Trippple Helix
Dr Zolman leads the biomarkers science at the world's most advanced experimental consumer longevity gene therapy program. trippplehelix.com
Skin Stories Clinic
Dr Zolman co-founded SkinStories in 2024, a holistic skin health service providing personalised treatments based on biomarkers testing, digital hub consultations with various specialists and onsite clinic visits. skinstories.clinic
Charity & Venture Fund
Funding therapies stuck in research that can rejuvenate highly important organs: with randomised controlled trials (RCTs) that meet CONSORT criteria.
GeekFood
Where science meets seasoning: geek.food
Rejuvenation Olympics (Defunct)
Dr Zolman created rejuvenationolympics.com however the rules changed for marketing purposes and it no longer holds any research use.
Founder Project Blueprint (Defunct)
Dr Zolman used his Longevity Level 123 protocol on his client Bryan Johnson, which Bryan called 'Project Blueprint'.
Specialist Consultancy in Experimental Evidence-Based Rejuvenation.
20one Consulting aim to be the first to prove N=1 Longevity Escape Velocity, through rigorously peer-reviewed studies, including showing evidence individuals are 25% younger in all 81 organ types & multi-organ clocks by 2030.
The Longevity Level 1, 2, 3 framework was made to integrate all evidence-based longevity tests & therapies, including pre-commercial ones, into a single, adaptive, personalised experimental protocol
The protocol provides the maximum theoretical chance of reaching age 100+ in good health compared to any other health protocol globally given it is a 'meta' protocol/guideline that incorporates all others
Longevity Level 1
Maintaining Level 1 from a young age *may* give an average person up to 95% chance of living to age 75, with high health expectancy.
As based on predominantly retrospective epidemiological data.
Longevity Level 2
Completing Level 2 *may* give the averge person increased quality of life up to age 75, but likely has insufficient evidence for increasing life expectancy beyond this age in people already doing Level 1
Longevity Level 3
Level 3 therapies are theoretically likely required to have >95% certainty of being healthy past age 75
Level 3 includes tests and therapies
Tests: Measure biological age accurately in each of the 81 organ types in individuals, as well as multi-organ biological age tests. Biostatistical accuracy is according to peer-reviewed Zolman Biological Age Marker Criteria (Z-BAM) (currently under NDA) with a strict biostatistical testing methodology.
Therapies: Use of all existing clinical practice guidelines for ageing conditions across all medical specialties is included in Level 3, e.g. statins, blood pressure medication, or cardiac or cancer surgery, with the additional use of further Level 3 Therapy Experimental Clinical Practice Guidelines for therapies that lack sufficiently good guidelines, all of which are AGREE-II and IPDAS compliant. Level 3 therpaies are organ or multi-organ targeted and attempt experimental reversal of the biological age of each organ in individuals.
